Efficacy and Safety Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening as Add-on to Oral Antidiabetic Drug(s) in Patients With Type 2 Diabetes
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 07 Jul 2009 Planned number of patients changed from 501 to 503 as reported by ClinicalTrials.gov.
- 07 Jul 2009 Actual end date (Feb 2006) added as reported by ClinicalTrials.gov.